Member access

4-Traders Homepage  >  Shares  >  Euronext Paris  >  SANOFI    SAN   FR0000120578

SANOFI (SAN)

2435
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo SANOFI
Engages in the research, production and distribution of pharmaceutical products

Sanofi engages in the research, production and distribution of pharmaceutical products.

The company operates through the following segments: Pharmaceuticals, Human Vaccines and Animal Health.

The Pharmaceuticals segment includes research, development, production and sales activities relating to pharmaceutical products, including prescription, consumer health care, and generic products.

This segment also includes equity affiliates and joint ventures with pharmaceutical business activities.

The Human Vaccines segment includes research, development, production and marketing.

The Animal Health segment comprises the research, development, production and marketing activities for vaccines.

It offers a range of medicines and vaccines on animal species.

The company was founded in 1994 and is headquartered in Paris, France.

Number of employees : 112 128 persons.
Sales per Businesses
20122013Delta
EUR (in Million)%EUR (in Million)%
Pharmaceuticals28,87182.6%27,25082.7% -5.95%
Human Vaccines3,89711.2%3,71611.3% -4.87%
Animal Health2,1796.2%1,9856% -9.77%
Managers
NameAgeSinceTitle
Igor Landau, MBA702004Member-Supervisory Board
Robert Castaigne, PhD682000Independent Director
Thierry M. Desmarest692000Director
Jean-René Fourtou752004Independent Director
Claudie Haigneré MD, PhD572008Independent Director
Uwe Bicker PhD, MD692008Independent Director
Karen Linehan551996Senior VP-Legal Affairs & General Counsel
Jérôme Contamine562009Chief Financial Officer & Executive Vice President
Roberto Pucci512009Senior Vice President-Human Resources
Gérard van Kemmel, MBA752003Independent Director
Shareholders
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Surperformance© rating
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
PER
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
NOVARTIS AG
ROCHE HOLDING LTD..
PFIZER INC.
MERCK & CO., INC.
SANOFI
GLAXOSMITHKLINE P..
BAYER AG
NOVO NORDISK A/S
BRISTOL-MYERS SQU..
ELI LILLY AND CO
ABBOTT LABORATORI..
ACTAVIS PLC
TEVA PHARMACEUTIC..
ALLERGAN, INC.
SHIRE PLC
VALEANT PHARMACEU..
TAKEDA PHARMACEUT..
REGENERON PHARMAC..
CSL LIMITED
Sector Pharmaceuticals
Company contact information
54 rue la Boétie
FR-75008 Paris
France

Phone : +33 (0)1 53 77 40 00
Fax : +33 (0)1 53 77 44 63
Internet : http://www.sanofi.com
Markets and indexes
- PEA / SRD eligible : YES / YES
- NYSE Euronext Paris
- Compartiment A
- CAC 40 / CAC All Shares, CAC All-Tradable, CAC Large 60, Euronext 100, EuroStoxx 50, FTSE Eurotop 100, Stoxx Europe 50, Stoxx France 50, Stoxx Global 200
Stock Exchange Codes
- ISIN Code :  FR0000120578
- Bloomberg Code :  SAN:FP
- Reuters Code :  SASY.PA
- Datastream Code :  F:SQ@F
© 2014 Factset    © 2014 Cofisem   
Dynamic quotes  
ON
| OFF